ArticleFrontiers in genetics2026
Leveraging Hamiltonian neural flow for robust single-cell multi-omics integration: application to Alzheimer's disease.
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's disease (AD) progression involves complex molecular interactions across multiple biological layers, yet integrating high-dimensional single-cell multi-omics data remains computationally challenging. While Graph Convolutional Networks (GCNs) effectively model cell-gene interaction topologies, they face three critical limitations: over-smoothing in deep architectures, instability under data perturbations, and lack of mechanistic interpretability-obstacles that impede clinical translation. The Hamiltonian Graph Convolutional Network (HGCN), a physics-inspired framework integrating symplectic dynamics with graph-based learning, is proposed in this study, which incorporates energy-conserving Hamiltonian mechanics to address these limitations through: (1) geometric constraints that prevent over-smoothing, (2) stable gradient propagation via symplectic integration, and (3) interpretable phase space representations of cellular states. To validate the effectiveness of the HGCN model, it was evaluated on three single-cell multi-omics datasets: an AD prefrontal cortex dataset, and peripheral blood benchmarks. Meanwhile, differential analysis emerged as the most effective feature extraction strategy in the evaluated experimental setting through systematic preprocessing comparisons. On the AD composite classification task requiring simultaneous prediction of cell type and disease state, HGCN achieved 92.28% accuracy and 0.9228 F1-score, significantly outperforming baseline GCN (88.59% accuracy, 0.8860 F1-score). Phase space visualization revealed biologically meaningful patterns: Inhibitory neurons exhibited heterogeneous subtype structures, while disease states showed symmetric geometric organization suggesting cell-type-invariant pathological mechanisms. Robustness experiments on citation networks demonstrated superior resilience to both feature and structural perturbations compared to standard GCN, with performance advantages increasing under higher perturbation intensities. These results establish HGCN as a robust, interpretable framework for multi-omics integration in complex disease analysis, with potential applications in precision medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.